Search Results for "Epidemiology Of Psoriatic Arthritis Uk"
Original Source: Psoriatic arthritis : A permanent challenge for rheumatologists and patients - Part 1: epidemiology, pathogenesis and clinical course.
Psoriatic arthritis is still one of the big challenges in rheumatology due to the great variety of symptoms. Treatment frequently requires an interdisciplinary collaboration of general practitioners, dermatologists and rheumatologists who are able to recognize the onset of disease early by means of classification criteria and new imaging techniques followed by the implementation of appropriate antirheumatic treatment. During recent years new immunological pathways have been discovered leading to an increasi...
Matching Channels
Arthritis - publications, news, reports
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are ma...
Technical Background Tumor necrosis factor (TNF) is a substance made by your body's immune system. People with inflammatory diseases such as rheumatoid arthritis, plaque psoriasis, psoriatic a...
Matching News
RA Drug Fails to Curb Psoriatic Arthritis (CME/CE)
(MedPage Today) -- Treatment with methotrexate, the cornerstone disease-modifying therapy in rheumatoid arthritis, had no benefit on synovitis in patients with active psoriatic arthritis, a placebo-co...
Psoriatic Arthritis Improved With Ustekinumab
The first interleukin inhibitor tested in phase 3 studies shows promise for psoriatic arthritis. Medscape Medical News
Etanercept for Psoriatic Arthritis With Recurrent Lymphoma
Does the use of TNF inhibitors for psoriatic arthritis increase the risk for recurrence of previously treated lymphoma? Journal of Clinical Rheumatology
Obesity, Psoriatic Arthritis Linked (CME/CE)
(MedPage Today) -- Women who are obese are at increased risk of developing psoriatic arthritis whether or not they already have psoriasis, a large, prospective study indicated.
Leflunomide considered safe, effective for psoriatic arthritis
(HealthDay)—Leflunomide is effective for the treatment of patients with psoriatic arthritis (PsA) in daily clinical practice, according to a study published online Oct. 6 in Arthritis Care & Researc...
Cimzia Succeeds in Psoriatic Arthritis (CME/CE)
BERLIN (MedPage Today) -- Response rates to the tumor necrosis factor inhibitor certolizumab pegol among patients with active psoriatic arthritis were twice those seen with placebo in a phase 3 study,...
New Drug Looks Good in Psoriatic Arthritis
WASHINGTON (MedPage Today) -- The investigational drug apremilast, a phosphodiesterase 4 inhibitor, appears to improve outcomes among patients with psoriatic arthritis when compared with placebo, r...
Switching TNF Drugs Works in Psoriatic Arthritis (CME/CE)
(MedPage Today) -- BIRMINGHAM, England -- Most patients with psoriatic arthritis responded well to a first-line biologic, but for many of those who didn't initially respond, switching to another agent...
Matching PubMed Articles
Psoriatic arthritis is an inflammatory rheumatic disorder, which occurs in patients with skin and/or nail psoriasis. In psoriatic arthritis, the importance of biologic mediators modulating inflammator...
HLA-B27 frequency in a group of patients with psoriatic arthritis.
HLA-B27 is associated with spondyloarthritis, a group of diseases that includes psoriatic arthritis.
Prospective new biologic therapies for psoriasis and psoriatic arthritis.
Psoriasis and psoriatic arthritis are immune-mediated, chronic, inflammatory diseases that place a heavy burden on the lifestyle of patients affected. Current understanding of the pathophysiology of t...
To assess the safety and efficacy of abatacept, a selective T cell costimulation modulator, in patients with psoriatic arthritis (PsA).
